Clinical Trial Update: RTI-336 as a Treatment for Methamphetamine Dependence [Phase 1]

View source ↗

Summary

The document reports the withdrawal of a Phase 1 trial evaluating RTI-336 for methamphetamine dependence. The study, sponsored by Baylor College of Medicine, is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Dependence
• Substance Use Disorder

Drugs mentioned

• RTI-336

Snippet

Sponsor: Baylor College of Medicine | Conditions: Methamphetamine Dependence, Substance Abuse | Phase 1 | Status: WITHDRAWN